To predict how heterogeneous expression of these NF-κB transcription factor components within DLBCL might affect the composition of NF-κB dimers and how the disease responds to its microenvironment, we used an established computational model of NF-κB signaling in B cells (54, 56). The gene discussed is NFKB1; the disease is diffuse large B-cell lymphoma.